• FirefoxInstall the new Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.57%

    PDL BioPharma, Inc. (PDLI)

    -NasdaqGS
    7.04 Down 0.03(0.42%) 4:00PM EDT
    |After Hours : 7.04 0.00 (0.00%) 4:33PM EDT
    Add to Portfolio
    Prev Close:7.07
    Open:7.06
    Bid:6.96 x 1000
    Ask:7.02 x 400
    1y Target Est:7.50
    Beta:0.63
    Earnings Date:May 11 - May 15 (Est.)
    Day's Range:7.03 - 7.17
    52wk Range:6.52 - 10.26
    Volume:2,854,730
    Avg Vol (3m):3,525,460
    Market Cap:1.15B
    P/E (ttm):3.78
    EPS (ttm):1.86
    Div & Yield:0.60 (8.20%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    PDLIDown 0.42%1.15B
    AMGNUp 1.27%123.38B
    SGENUp 1.40%4.50B
    XOMAUp 1.39%422.91M

    Key Statistics

    Forward P/E (1 yr):8.91
    P/S (ttm):2.36
    Ex-Dividend Date:02-Dec-15

    Analysts

    Annual EPS Est (Dec-15) :2.20
    Quarterly EPS Est (Mar-15) :0.52
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):0.23

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    PDL BioPharma, Inc. manages a portfolio of patents and royalty assets in the United States and Europe. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback